We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Evolving FDA Inspection Process Will Place Greater Pressure on Managers, Official Says
Evolving FDA Inspection Process Will Place Greater Pressure on Managers, Official Says
June 23, 2006
Managers at device and diagnostics manufacturing facilities can expect to bear the brunt of accountability for lapses in their quality systems (QS), a compliance official with the FDA's Center for Devices and Radiological Health (CDRH) said at a recent industry conference.